Novanta (NOVT) stock
Last close $101.99 on 2026-11-20 (-11.22%) · Sector: Technology
Novanta is a Massachusetts-based technology company that designs precision components, lasers, sensors, and imaging tools. Its main customers are medical device and advanced industrial equipment makers (called OEM customers), which build its parts into their own products, and it earns money mainly from selling those components and systems.
Novanta's revenue is growing, with trailing 12-month revenue of about $1.1 billion, up 14.6%, but profit margins have narrowed in recent quarters. The stock has returned -6.2% over the past year while the S&P 500 gained 3.2%, so it has lagged the market, and it trades 42.2% below its 52-week high. A director and the CEO have sold shares in 2026, and the stock has moved sharply after earnings reports, with moves ranging from -15.3% to +13.7% the next day.
Key numbers
- Market cap: $4.4B
- Revenue (last 12 months): $1.10B
- Revenue growth: +14.6%
- Gross margin: 44.5%
- Operating margin: 7.3%
- P/E: 77.3
- P/S: 4.0
- Debt to equity: 0.48
- Current ratio: 1.17
Quality score
Overall 30/100 · growth 42 · profitability 29 · financial health 50 · value 0
Performance and risk
1-year return -6.2% vs S&P 500 +3.1% · volatility 52.1% (S&P 500 14.2%) · largest drop -39.6% · beta 1.97
Stock move the day after earnings
- 2026-02-23: -3.5%
- 2026-05-11: +13.7%
- 2026-08-05: +6.7%
- 2026-11-09: -15.3%
Insider trades (12 months)
Bought $0.0M · sold $11.5M
NOVT stock research · NOVT options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.